
ENLV Market Capitalization Overview
Market Cap: $21.47M as of Jun 13, 2025
$21.47M
Past Month-$3.11M (12.62%)
As of Jun 13, 2025, ENLV has a market capitalization of $21.47M. Over the past 30 days, its market cap has decreased by -2.9%, while in the last 12 months, it has decreased by -16.57%.
Market capitalization represents the total value of Enlivex Therapeutics Ltd as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
ENLV Market Cap Formula = Stock Price * Shares Outstanding
The market cap of ENLV helps investors assess the company's size and compare it with competitors for better investment decisions.
Market capitalization represents the total value of Enlivex Therapeutics Ltd as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
ENLV Market Cap Formula = Stock Price * Shares Outstanding
The market cap of ENLV helps investors assess the company's size and compare it with competitors for better investment decisions.
ENLV Market Cap & Key Trends
See Enlivex Therapeutics Ltd’s latest market capitalization, historical trends, and financial insights with AI-powered fundamental data and custom analysis.
Start investing in ENLV
Order type
Buy in
Order amount
Est. shares
0 shares
ENLV Market Cap History
Date | Market Cap | Change |
---|---|---|
Jun 2, 2025 | $22.42M | -2.90% |
May 1, 2025 | $23.09M | +10.53% |
Apr 1, 2025 | $20.89M | -6.86% |
Mar 3, 2025 | $22.43M | -5.56% |
Feb 3, 2025 | $23.75M | -12.90% |
Jan 2, 2025 | $27.27M | +17.94% |
ENLV End of Year Market Cap History
Date | Market Cap | Change |
---|---|---|
2025 | $21.47M | -16.57% |
2024 | $25.73M | -48.74% |
2023 | $50.20M | -30.74% |
2022 | $72.47M | -36.75% |
2021 | $114.57M | +0.94% |
2020 | $113.50M | — |
FAQs About Enlivex Therapeutics Ltd (ENLV) Market Cap
As of Jun 13, 2025, the market capitalization of ENLV is $21.47M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.
In the last 30 days, Enlivex Therapeutics Ltd’s market capitalization has decreased by -12.62%, changing from $24.57M to $21.47M as of Jun 13, 2025.
In the last 3 months, Enlivex Therapeutics Ltd’s market capitalization has increased by —, changing from – to – as of –.
In the year 2024, Enlivex Therapeutics Ltd’s market capitalization decreased from $50.20M in January to $25.73M in December, reflecting a -48.74% change.
In the past five years, ENLV has had a compound annual growth rate (CAGR) of -25.68% in market capitalization. This means its market cap has shrunk at an average rate of -25.68% per year.